Increased CXCL13 levels are detected in plasma and SG from pSS patients [1,103], and increased serum CXCL13 concentrations have been correlated with aberrant B cell parameters even associated with lymphoma development [104]. This evidence concerns the gene CXCL13 and peeling skin syndrome.